ResMed Inc. is a holding company. The Company, through its subsidiaries, in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. Its segments include Sleep and Breathing Health segment and the Residential Care Software segment. It also operates a Software as a Service (SaaS) business in the United States and Germany that includes out-of-hospital software platforms designed to support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. Its products and solutions are designed to improve patients' quality of life and reduce the impact of chronic disease. Its cloud-based digital health software applications, along with its devices, are designed to provide connected care.
高成長
同社の収益は過去3年間にわたり着実に増加しており、年平均で21.86%の成長率を示しています。
高い利益成長
同社の純利益は業界をリードしており、最新の年間純利益はUSD 56.06です。
高配当
同社は高配当銘柄であり、最新の配当性向は22.19%です。
安定配当
同社は過去5年間にわたり継続的に配当を実施しており、最新の配当性向は22.19%です。
適正水準
同社の最新のPEは28.31で、過去3年間の水準と比較して適正圏にあります。
機関投資家の売り越し
最新の機関投資家の保有株数は96.52M株で、前四半期比で8.11%減少しています。
バンガードが保有
スター投資家バンガードは本銘柄を18.68M株保有しています。